Zhuzhou Qianjin Pharmaceutical Co., Ltd. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhuzhou Qianjin Pharmaceutical Co., Ltd. with three other
companies in this sector in China:
Guangxi Wuzhou Zhongheng Group, Ltd.
sales of 3.30 billion Chinese Renmimbi [US$493.17 million]
of which 96%
was Pharmaceutical Segment),
Jilin Aodong Medicine Industry (Group) Co., Ltd.
(3.32 billion Chinese Renmimbi [US$497.01 million]
of which 95%
was Pharmaceutical Manufacturing), and
Guangdong Taiantang Pharmaceutical Co Ltd
(3.31 billion Chinese Renmimbi [US$495.37 million]
of which 70%
was Medicine Wholesale & Retail).
During the year ended December of 2018, sales at
Zhuzhou Qianjin Pharmaceutical Co., Ltd. were 3.33 billion Chinese Renmimbi (US$497.64 million).
increase of 4.6%
versus 2017, when the company's sales were 3.18 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Zhuzhou Qianjin Pharmaceutical Co., Ltd.
(and since 2013, sales have increased a total of 69%).